Suchergebnisse - "Sarilumab"

PubPharm (21)

1

Safety and effectiveness of sarilumab in Japanese patients with rheumatoid arthritis refractory to previous treatments : An interim analysis of a post-marketing surveillance

enthalten in: Modern rheumatology | 2024

von Kameda, H. | Tasaka, S. | Takahashi, T. | +3

2

Anti-GM-CSF otilimab versus sarilumab or placebo in patients with rheumatoid arthritis and inadequate response to targeted therapies : a phase III randomised trial (contRAst 3)

enthalten in: Annals of the rheumatic diseases | 2023

von Taylor, P. | Weinblatt, M. | McInnes, I. | +18

3

Pharmacokinetics, pharmacodynamics, and safety of single-dose subcutaneous sarilumab with or without methotrexate in Japanese patients with rheumatoid arthritis : Two single-dose studies

enthalten in: Modern rheumatology | 2023

von Ishii, T. | Sato, Y. | Munakata, Y. | +6

4

A Woman with Rheumatoid Arthritis Who Successfully Delivered a Healthy Child with Continuous Administration of Sarilumab Throughout Pregnancy

enthalten in: Internal medicine (Tokyo, Japan) | 2023

von Mizutani, S. | Okunishi, Y. | Tamada, T. | +7

5

Lessons learned from the preclinical discovery and development of sarilumab for the treatment of rheumatoid arthritis

enthalten in: Expert opinion on drug discovery | 2022

von Maioli, G. | Caporali, R. | Favalli, E.

6

Immunogenicity of sarilumab and impact on safety and efficacy in Japanese patients with rheumatoid arthritis : analysis of two Phase 3 randomised clinical trials

enthalten in: Modern rheumatology | 2022

von Tanaka, Y. | Takahashi, T. | Sumi, M. | +5

7

Sarilumab monotherapy vs sarilumab and methotrexate combination therapy in patients with rheumatoid arthritis

enthalten in: Rheumatology (Oxford, England) | 2022

von Burmester, G. | Bykerk, V. | Buch, M. | +6

8

Drugs for rheumatoid arthritis

enthalten in: The Medical letter on drugs and therapeutics | 2021

9

Expanded Table : Some biologic drugs and JAK inhibitors for rheumatoid arthritis

enthalten in: The Medical letter on drugs and therapeutics | 2021

10

Long-term safety and efficacy of sarilumab over 5 years in patients with rheumatoid arthritis refractory to TNF inhibitors

enthalten in: Rheumatology (Oxford, England) | 2021

von Fleischmann, R. | Genovese, M. | Maslova, K. | +3

CommentIn: Rheumatology (Oxford). 2021 Nov 3;60(11):4953-4955. - PMID 33974043